Literature DB >> 15570934

[Measurement of docetaxel concentration in blood and ascites after drip infusion into each vessel and intraperitoneal cavity of gastric cancer].

Hiroyuki Naitoh1, Akira Kawaguch, Hiroshi Yamamoto, Eiji Mekata, Tohru Tan, Hiroaki Morii, Mikio Chiba.   

Abstract

We measured docetaxel (TXT) concentrations in the blood and ascites after drip infusion into each vessel and intraperitoneal cavity of a patient with advanced gastric cancer. The peak concentration was reached immediately (first time 244 ng/ml, second time 215 ng/ml) after the infusion of TXT (25 mg/m2) into the vessels. The concentration of TXT for ascites peaked after 30 min of drip infusion (first time 26 ng/ml, second time 30 ng/ml). AUC ascites/AUC blood was 27.2% and 35.8% respectively. This is the first report demonstrating the concentration of TXT in ascites after drip infusion into vessels. When TXT was administered into the peritoneal cavity, the peak concentration of ascites was reached immediately (54,200 ng/ml). After 240 min, the TXT concentration in the peritoneal cavity was still high (14,200 ng/ml). In blood, the level peaked (64 ng/ml) at 120 min. After 240 min, the TXT level in the blood remained 44 ng/ml. AUC blood/AUC ascites was only 0.25%. These results suggested that the transition rate of TXT from blood to intraperitoneal cavity was excellent, and that TXT was suitable for the treatment of peritoneal dissemination of gastric cancer. Furthermore, infusion of TXT (25 mg/m2) into the peritoneal cavity may directly and systemically provide its antitumor effect. If we prefer the antitumor effect directly, a much lower dose infusion of TXT may be recommended.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15570934

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  5 in total

1.  Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study.

Authors:  Lingyun Zhang; Jiayu Zhang; Yan Wang; Wei Li; Shan Yu; Qian Li; Yiyi Yu; Tianshu Liu; Yuehong Cui
Journal:  BMC Gastroenterol       Date:  2022-06-14       Impact factor: 2.847

2.  Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway.

Authors:  Toshifumi Shinbo; Sachio Fushida; Tomoya Tsukada; Shinichi Harada; Jun Kinoshita; Katsunobu Oyama; Koichi Okamoto; Itasu Ninomiya; Hiroyuki Takamura; Hirohisa Kitagawa; Takeshi Fujimura; Masakazu Yashiro; Kousei Hirakawa; Tetsuo Ohta
Journal:  Oncol Rep       Date:  2014-11-28       Impact factor: 3.906

3.  In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening.

Authors:  Cheng-Guang Wu; Francesca Chiovaro; Alessandra Curioni-Fontecedro; Ruben Casanova; Alex Soltermann
Journal:  J Transl Med       Date:  2020-04-10       Impact factor: 5.531

4.  Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.

Authors:  S Fushida; J Kinoshita; M Kaji; Y Hirono; F Goda; Y Yagi; K Oyama; Y Sudo; Y Watanabe; T Fujimura
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-20       Impact factor: 3.333

Review 5.  Regional but fatal: Intraperitoneal metastasis in gastric cancer.

Authors:  Jia Wei; Nan-Die Wu; Bao-Rui Liu
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.